China-based Pharmaceutical Company Seeking M&A Targets

A China-based pharmaceutical company is seeking candidate companies for M&A purpose.  This Chinese company is well-established in the China market and produces a wide range of pharmaceutical products. The latest annual revenue of the candidate should ideally be in the range of US$ 50 million -- 100 million, and its key products should have passed regulatory certifications in its main markets. Private companies will be preferred over public companies as candidates. The Chinese company will prefer to acquire a majority stake, and may settle as a minority shareholder if it can be represented in the target’s board of directors.